Variables to Be Monitored via Biomedical Sensors for Complete Type 1 Diabetes Mellitus Management: An Extension of the “On-Board” Concept

الملخص EN

Type 1 diabetes mellitus (DM1) is a growing disease, and a deep understanding of the patient is required to prescribe the most appropriate treatment, adjusted to the patient’s habits and characteristics.

Before now, knowledge regarding each patient has been incomplete, discontinuous, and partial.

However, the recent development of continuous glucose monitoring (CGM) and new biomedical sensors/gadgets, based on automatic continuous monitoring, offers a new perspective on DM1 management, since these innovative devices allow the collection of 24-hour biomedical data in addition to blood glucose levels.

With this, it is possible to deeply characterize a diabetic person, offering a better understanding of his or her illness evolution, and, going further, develop new strategies to manage DM1.

This new and global monitoring makes it possible to extend the “on-board” concept to other features.

This well-known approach to the processing of variable “insulin” describes some inertias and aggregated/remaining effects.

In this work, such analysis is carried out along with a thorough study of the significant variables to be taken into account/monitored—and how to arrange them—for a deep characterization of diabetic patients.

Lastly, we present a case study evaluating the experience of the continuous and comprehensive monitoring of a diabetic patient, concluding that the huge potential of this new perspective could provide an acute insight into the patient’s status and extract the maximum amount of knowledge, thus improving the DM1 management system in order to be fully functional.